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Introduction
Cardiovascular disease accounts for approximately half
the deaths among adults with end-stage renal disease
(ESRD) undergoing regular dialysis.1,2 Cardiovascular
mortality in ESRD patients is 10–20 times higher
than in the general population, even after stratifica-
tion by age, gender, race, and presence of diabetes.1
The excessive relative risk of cardiovascular mortality is
much more pronounced in younger ESRD patients.1,2
In the general population, cardiovascular mortality
increases sharply with advancing age. In contrast, the
effect of aging on cardiovascular mortality is much
less obvious in patients with ESRD.1 Children and
young adults with ESRD die primarily of cardiovascu-
lar disease, and the mortality risk from cardiovascular
disease is higher than that from infection or malig-
nancy.3,4 Several hypotheses have been proposed to
explain the excess cardiovascular morbidity and mor-
tality in young ESRD patients, including enhanced
atherosclerosis,5 uremic cardiomyopathy,6,7 and uremic
vasculopathy.8
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Augmentation index and pulse wave velocity in ESRD
Increased arterial pulsatile load is a major cause of
the high cardiovascular morbidity and mortality in
ESRD patients undergoing regular hemodialysis.9
Specifically, increased aortic stiffness determined by
measurement of aortic pulse wave velocity (PWV) is 
a strong independent predictor of all-cause and mainly
cardiovascular mortality,10 and the insensitivity of
PWV to decreased blood pressure is an independent
predictor of mortality in patients with ESRD.11 Arte-
rial wave reflections, estimated by the carotid aug-
mentation index (AI), play an important role in the
mechanisms producing alterations in pulsatile arterial
dynamics in ESRD,12 and AI is an independent pre-
dictor of all-cause and cardiovascular mortality in these
patients.13
In healthy, normotensive individuals, age-related
changes in AI are more prominent in younger indi-
viduals (< 50 years), whereas changes in PWV are
more marked in older individuals (≥ 50 years).14
Therefore, the present study was done to investigate
whether or not the differential effects of age on AI
and PWV also existed in ESRD patients. The results
may partly explain the observed high cardiovascular
mortality in young patients with ESRD.1
Methods
Study subjects
A total of 257 patients with ESRD (129 males, 128
females; mean age, 53.9 ± 15.0 years) without previ-
ous history of cardiovascular disease and who had
been on hemodialysis for at least 6 months were
invited to participate in a comprehensive hemody-
namic study; some of the data were published previ-
ously.15–17 Patients with significant valvular heart
diseases were not included. Another 260 healthy vol-
unteers (136 males, 124 females; mean age,
51.4 ± 17.8 years) with normal renal function were
enrolled as normal controls. Written informed con-
sent approved by our Institutional Review Board 
was obtained from every subject before entry into 
the study. All ESRD patients received a 4-hour dialy-
sis session thrice-weekly using 1.6 m2 surface area 
dialyzers with bicarbonate-based dialysate (Na+
140 mmol/L, HCO3− 39 mmol/L, K+ 2.0 mmol/L,
Ca2+ 3.0 mmol/L and Mg2+ 1.0 mmol/L). Compre-
hensive evaluation of cardiovascular structure and
function in ESRD patients was performed on a non-
dialysis day. The duration on dialysis ranged from 6 to
269 months, with mean dialysis duration around 43
months. The main causes for dialysis included
glomerulonephritis (41%), diabetes mellitus (16%),
polycystic kidney disease (2%), hypertension (11%),
and others (30%).
Vascular parameters
Supine brachial artery systolic (SBP) and diastolic
blood pressures (DBP) were measured with an oscil-
lometric device. Pulse pressure was the difference
between SBP and DBP.
Echocardiography was analyzed according to the
American Society of Echocardiography criteria with a
SONOS 5500 system (Agilent Technologies, Andover,
MA, USA) incorporated with a multifrequency trans-
ducer. Each echocardiographic parameter was the
mean value of 4 consecutive measurements. The
measured arterial structural parameters included aor-
tic root and common carotid artery (CCA) diameter,
and CCA intima-media thickness (IMT).18
The arterial functional parameters included PWV
and AI. PWV was measured by recording pulse waves
at the right CCA and the right femoral artery sequen-
tially using tonometry and a simultaneous electrocar-
diogram.12,16,19,20 AI was analyzed from the right CCA
pressure wave contour according to the method of
Murgo et al.16,21 AI was the ratio of the augmented
pressure, which was determined as the height of the
late systolic peak above the inflection point, to the
pulse pressure, in percentage.
Left ventricular parameters
Left atrial dimension was determined by M-mode
echocardiography. Left ventricular mass and ejection
fraction were calculated from M-mode measure-
ments.16,22 Stroke volume was measured by pulse-
wave Doppler echocardiography. Left ventricular
end-diastolic volume was calculated from stroke vol-
ume divided by ejection fraction. Left ventricular
end-systolic volume was the difference between left
ventricular end-diastolic volume and stroke volume.
Left ventricular end-systolic elastance (Ees) is a key
determinant of cardiac systolic function and ventricular-
arterial interaction not susceptible to loading change.23
Ees was estimated with a recently proposed single-beat
method employing SBP, DBP, SV, left ventricular ejec-
tion fraction, and an estimated normalized ventricular
elastance at arterial end-diastole [E(Nd)]: Ees = [DBP −
(E(Nd) × SBP × 0.9)]/[E(Nd) × SV], where E(Nd) was
estimated from a group-averaged value adjusted for
individual contractile/loading effects.24
Statistical analysis
Study subjects were divided into 4 groups, namely,
younger normal controls (< 50 years), older normal
controls (≥ 50 years), younger ESRD patients (< 50
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years), and older ESRD patients (≥ 50 years). Age-
related changes were calculated as the mean differences
of cardiovascular parameters between the older and
younger subjects divided by values in the younger
subjects. Similarly, the changes related to ESRD were
calculated as the mean differences in cardiovascular
parameters between ESRD patients and normal con-
trols divided by values in the normal controls. Because
AI itself is a ratio expressed as a percentage, group dif-
ferences in AI were calculated instead of the percent
change. All continuous parameters are expressed as
mean ± standard deviation. Between-group differences
were assessed by t test. The interaction between groups
was tested by general linear regression. Linear regres-
sion analyses were also performed to examine the dif-
ferent age-related effects on PWV and AI in ESRD
patients and normal controls. Statistical significance was
set at p < 0.05, and all tests were 2-sided.
Results
Abnormal cardiovascular structure and
function in ESRD patients
The general characteristics of ESRD patients and nor-
mal controls are shown in Table 1. The normal con-
trols and ESRD patients were similar in age and
gender distribution. Compared to normal controls,
ESRD patients were shorter in height, had lower
body weight and smaller body mass index. Yet, ESRD
patients had significantly higher SBP, DBP, pulse
pressure, and heart rate than normal controls.
Table 1. Characteristics of study subjects*
Normal controls (n = 260) ESRD patients (n = 257) p
Age (yr) 51.4 ± 17.8 53.9 ± 15.0 0.082
Sex (men) 136 129 0.6308
Hematocrit (%) 39.8 ± 4.1 30.1 ± 4.3 <0.0001
BMI (kg/m2) 23.6 ± 3.5 22.8 ± 3.5 0.0125
Height (cm) 162.8 ± 8.6 159.7 ± 8.5 <0.0001
Weight (kg) 62.7 ± 11.9 58.2 ± 10.5 <0.0001
Waist circumference (cm) 79.3 ± 10.4 80.2 ± 10.5 0.3311
Systolic BP (mmHg) 118.9 ± 16.1 133.4 ± 29.8 <0.0001
Diastolic BP (mmHg) 68.9 ± 11.1 76.0 ± 17.1 <0.0001
Pulse pressure (mmHg) 50.0 ± 10.6 57.4 ± 18.9 <0.0001
Heart rate (beats/min) 66.9 ± 9.8 76.1 ± 13.5 <0.0001
Cardiac structure
LA (mm) 32 ± 5 35 ± 6 <0.0001
LVEDV (mL) 61 ± 16 73 ± 28 <0.0001
LVESV (mL) 23 ± 9 33 ± 20 <0.0001
LVM (g) 144 ± 44 207 ± 68 <0.0001
Cardiac function
EF (%) 74 ± 7 68 ± 12 <0.0001
Ees (mmHg/mL) 3.1 ± 1.1 2.8 ± 1.1 0.003
Vascular structure
Aorta (mm) 30 ± 4 31 ± 4 <0.0001
CCA inner diameter (mm) 5.5 ± 0.6 6.3 ± 1.0 <0.0001
IMT (× 100) (mm) 7.2 ± 1.6 8.2 ± 1.8 <0.0001
Vascular function
AI (%) 15.2 ± 19.0 22.5 ± 18.6 <0.0001
PWV (m/s) 8.3 ± 3.0 10.7 ± 4.6 <0.0001
*Data are presented as mean ± standard deviation or n. ESRD = end-stage renal disease; BMI = body mass index; BP = blood pressure; LA = left atrium; LVEDV =
left ventricular end-diastolic volume; LVESV = left ventricular end-systolic volume; LVM = left ventricular mass; EF = ejection fraction; Ees = end-systolic elas-
tance; CCA = common carotid artery; IMT = intima-media thickness; AI = carotid augmentation index; PWV = aortic pulse wave velocity.
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ESRD patients had obvious abnormalities in car-
diovascular structure and function. They had greater
left atrial and ventricular chamber size and left ven-
tricular mass, decreased left ventricular systolic func-
tion, greater aortic and CCA diameters and IMT, 
and increased AI and PWV, as compared to normal
controls.
Age-related changes in cardiovascular
structure and function
In both ESRD patients and normal controls, subjects
≥ 50 years had shortened height, enlarged waist cir-
cumference, and increased pulse pressure, left atrial
dimension, Ees, aorta and CCA diameters, IMT, and
AI and PWV, as compared to subjects aged < 50 years.
No significant changes in body weight, and left ven-
tricular end-diastolic and end-systolic dimensions
were observed in both groups. On the other hand,
body mass index increased significantly with age in
ESRD patients but not in normal controls. SBP, DBP,
left ventricular mass, and aortic diameter significantly
increased with age in normal controls but not in
ESRD patients (Table 2).
Differential effects of age on AI and PWV
In both men and women, younger and older, ESRD
patients had increased PWV compared to their
respective normal controls (Figure 1A). In subjects
< 50 years old, the ESRD-related percent difference in
PWV was greater in females than in males (p = 0.0017).
There was no significant interaction between age-
related changes and ESRD-related changes in PWV 
in men (p = 0.5452) and women (p = 0.0789). In con-
trast, in both men and women, there was a prominent
ESRD-related change in AI in subjects aged < 50 years
(Figure 1B). The interaction between age-related
changes and ESRD-related changes in AI was signifi-
cant in both men (p=0.0062) and women (p < 0.0001).
The differential effects of age on AI and PWV in
patients with ESRD were also obvious when the rela-
tionships of age versus AI and age versus PWV were
directly analyzed by linear regression (Figure 2). PWV
was linearly correlated with age in both ESRD patients
(PWV = 0.13 × age + 3.07; r = 0.2418, p < 0.0001) and
normal controls (PWV = 0.09 × age + 3.77; r = 0.4268,
p < 0.0001) in men, and the slope was slightly steeper
in ESRD patients (p = 0.049 for the interaction of the
slopes) (Figure 2A). Similarly, PWV was linearly cor-
related with age in both ESRD patients (PWV =
0.12 × age + 4.83; r = 0.1125, p = 0.0001) and normal
controls (PWV = 0.14 × age + 1.18; r = 0.4967, p <
0.0001) in women without significant interaction of
the slopes (p = 0.43) (Figure 2B). In contrast, although
AI was linearly correlated with age in both ESRD
patients (AI = 0.37 × age − 2.79; r = 0.1009, p = 0.0003)
and normal controls (AI = 0.69 × age − 25.21; r =
0.3778, p < 0.0001) in men, the slope was signifi-
cantly steeper in normal controls (p = 0.01 for the
interaction of the slopes) (Figure 2C). Furthermore,
AI was linearly correlated with age in normal controls
only (AI = 0.60 × age − 10.28; r = 0.3812, p < 0.0001)
and not in ESRD patients (AI = 0.08 × age + 23.45;
r = 0.0047, p = 0.4435) in women (p = 0.0001 for the
interaction of the slopes) (Figure 2D).
Discussion
Age-related increases in arterial stiffness and wave
reflection are partly responsible for increased cardio-
vascular morbidity and mortality in the elderly. In the
healthy population, age-related changes in AI are
more prominent in younger subjects, whereas changes
in large artery stiffness are more marked in older sub-
jects.14 The present study demonstrates that differen-
tial effects of age on AI and PWV exist in ESRD
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Figure 1. Differential end-stage renal disease (ESRD)-
related changes in carotid augmentation index (AI)
and aortic pulse wave velocity (PWV) in subjects
< 50 years and ≥ 50 years old. (A) Percent difference
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patients. PWV increased with age similarly in both
ESRD patients and normal controls. In contrast, AI
increased markedly in the younger but only slightly in
the older ESRD patients, so age-related increase in AI
was blunted in ESRD patients, especially in women.
The results may partly explain the observed high car-
diovascular mortality in younger patients with ESRD.1
Younger patients with ESRD suffer from excessive
cardiovascular mortality, which is increased 700-fold
in 25–34-year-old patients undergoing dialysis.1,25
Goodman et al demonstrated that coronary artery
calcification is common and progressive in young
adults with ESRD who are undergoing dialysis.8 Oh
et al reported that young adults with childhood-onset
chronic renal failure have a high prevalence of arteri-
opathy associated with indicators of microinflamma-
tion, hyperparathyroidism, calcium phosphate overload
and hyperhomocysteinemia, but not traditional athero-
genic risk factors.25 A particular phenotype of coro-
nary atherosclerosis has been described in uremic
patients, characterized by preferential thickening and
calcification of the tunica media.25,26 It appears that
the mechanisms underlying uremic arteriopathy may
be distinct from those causing atherosclerosis as part
of the aging process.25 Guerin et al showed that the
presence of vascular calcifications in ESRD patients was
associated with increased stiffness of large-capacity,
elastic-type arteries, like the aorta and CCA.11 In addi-
tion, increased arterial stiffness in young adults with
ESRD since childhood has been recognized.27 There-
fore, it is reasonable to speculate that increased pulsatile
load may be an important determinant of cardiovascular
mortality in younger patients with ESRD.
The increased effect of arterial wave reflections on
the aorta and central arteries causes increased pres-
sure during systole and decreased DBP and/or dias-
tolic tension-time index.28 These alternations increase
left ventricular oxygen requirements and predispose to
left ventricular hypertrophy and decreased coronary
perfusion with relative subendocardial ischemia.29,30
London et al showed that the association of ESRD
patients’ mortality with wave reflection (indexed by
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AI) was independent of arterial stiffening estimated as
PWV.13 The present study further suggests that the
excessive increase in AI in the younger ESRD patients
may partly explain the excessive cardiovascular mortal-
ity in these patients. This is supported by the accentu-
ated increase in left ventricular mass and aorta diameter
parallel to the change in AI in the younger ESRD
patients in this study. In ESRD patients, the relation
between early arterial wave reflection and left ventric-
ular hypertrophy in long-term dialysis has already been
defined, and the arterial wave reflection may alter car-
diac structure, resulting in left ventricular hypertrophy
independently of other factors.31
AI is affected by age, PWV, traveling distance of
pressure waves (body height), left ventricular ejection
time, and reflective properties of the arterial sys-
tem.31,32 PWV is directly related to aortic stiffness by
the Bramwell-Hill equation.32,33 The associations
between AI and age and between PWV and age in the
general population are well-recognized.14,32 In our
younger subjects, there were no significant differences
in height and the aging effect on PWV between the
normal controls and ESRD patients. Hence, the accen-
tuated increase in AI in young ESRD patients was
likely due to the accentuated increase in the reflective
properties of the vascular tree, which could be altered
independently of stiffening of the large arteries.32
Similar aging effects on PWV and pulse pressure
in both normal controls and ESRD patients suggest
uniform central vascular stiffening with aging since
childhood. The incremental effects of age and uremia
on aortic stiffness may provide a sound basis for PWV
as a strong independent predictor of all-cause and
mainly cardiovascular mortality in patients with
ESRD.10,11 On the other hand, aortic stiffening may
not be the cause of the excessive cardiovascular mor-
tality in the younger ESRD patients because PWV in
the younger ESRD patients was not higher than that
in the older normal controls, and the highest PWV
appeared in the older ESRD patients.
IMT is an early marker of atherosclerosis and a
predictor of vascular events.34,35 Oh et al reported that
IMT was significantly increased in young adults with
childhood-onset chronic renal failure compared with
matched control subjects, and it was associated 
with ESRD duration, cumulative dialysis time, and cu-
mulative serum calcium, phosphate and calcium phos-
phate product.25 In contrast, Groothoff et al showed
that IMT was not significantly increased in young
adults with ESRD compared to controls.27 In our
study, IMT seemed to increase with the presence of
ESRD and advancing age, and the highest IMT
occurred in the older ESRD patients.8,25 The results
may suggest that accelerated atherosclerosis is not the
main cause of the excessive cardiovascular mortality in
the younger ESRD patients, and may further under-
score the importance of pulsatile load as indexed by
AI in these patients.
In the normal population, young females are pro-
tected from cardiovascular mortality compared to
young males.1 The advantage of female gender on
cardiovascular mortality disappears in patients with
ESRD.1 In this study, the most striking findings were
that AI was very high in younger female ESRD
patients and AI did not increase with age as observed
in normal controls and male ESRD patients. These
results may suggest that increased wave reflection is
also a possible explanation for the high cardiovascular
mortality in the young female ESRD patients.
The present study used a cross-sectional design,
with its inherent limitations. Therefore, any con-
clusions from this study should be considered as
hypothesis generation. Other factors, such as dura-
tion of renal insufficiency and hemodialysis, history
of hypertension and diabetes, and presence of left
ventricular dysfunction and hyperparathyroidism
may also affect AI and PWV and may have con-
founded our results. Left ventricular ejection fracture
usually remains unchanged with advancing age in the
normal population. In the present study, the slightly
but statistically significantly increased ejection frac-
tion in the normal controls ≥ 50 years old as com-
pared with normal controls < 50 years old was
probably due to chance and did not have any clinical
significance.
In conclusion, markedly differential effects of age
on AI and PWV were observed in ESRD patients.
PWV increased with age similarly in both ESRD
patients and normal controls, whereas AI increased
markedly in the younger but only slightly in the older
ESRD patients. The differential effects of age on AI
and PWV appeared to be more prominent in female
ESRD patients. These results suggest that increased
pulsatile load may play an important role in the high
cardiovascular mortality in the younger, especially
female, ESRD patients.
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